Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that on January 20, 2025, the Human Capital Management Committee of Avidity's Board of Directors granted a non-qualified stock option award to purchase an aggregate of 10,500 shares of its common […]
NEW YORK CITY, NY / ACCESS Newswire / January 20, 2025 / If you suffered a loss on your Visa Inc. (NYSE:V) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/visa-inc-lawsuit-submission-form?prid=123952&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK CITY, NY / ACCESS Newswire / January 20, 2025 / If you suffered a loss on your ASP Isotopes Inc. (NASDAQ:ASPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/asp-isotopes-inc-lawsuit-submission-form?prid=123951&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com
NEW YORK CITY, NY / ACCESS Newswire / January 20, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/regeneron-pharmaceuticals-inc-lawsuit-submission-form?prid=123950&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com
NEW YORK, NY / ACCESS Newswire / January 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of FTAI Aviation Ltd. ("FTAI Aviation" or "the Company") (NASDAQ:FTAI). Investors who purchased FTAI Aviation securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site:
Denver Mattress Company and The Salvation Army Intermountain Division are celebrating another successful year of their “Together Doing Even More Good” holiday campaign. The annual initiative, which ran from Thanksgiving Day to Christmas Day 2024, raised an impressive $649,000 in donations, surpassing last year's total. https://mma.prnewswire.com/media/2259734/DMC_Logo.jpg Colorado-based Denver Mattress Company, continuing its 25-year tradition of
Attorney Advertising — Bronstein,Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. (“Regeneron” or “the Company”) (NASDAQ: REGN) and certain of its officers. https://mma.prnewswire.com/media/439152/Bronstein_Gewirtz_and_Grossman_LLC_logo.jpg Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities
BOXABL is thrilled to announce that its flagship product, the BOXABL Casita, has officially been approved under the Residential Building Code in the State of Nevada. https://mma.prnewswire.com/media/2601968/Boxabl_American_Campground.jpg BOXABL announces that its flagship product, the Casita, is now approved under the Residential Building Code in Nevada. The Casita offers an innovative, cost-effective housing solution that aligns
New York, NY, Jan. 20, 2025 (GLOBE NEWSWIRE) — Keynode, one of the leading innovators in the crypto staking ecosystem, is thrilled to announce the release of its Liquidity Pooled Staking, a game-changing service that combines liquidity and staking to get the best crypto staking rewards for investors. This new feature simplifies the staking process
(NasdaqGM:RVNC), NEW YORK, Jan. 20, 2025 (GLOBE NEWSWIRE) — Attorney Advertising–Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Revance Therapeutics, Inc. (“Revance” or “the Company”) (NASDAQ: RVNC) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants